Trial intelligence / Profile preview

Conivaptan infusions in hyponatremia

NCT00478192Phase 3Completed

Sponsor
Cumberland Pharmaceuticals
Start
Apr 2007
Primary completion
Aug 2008
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of conivaptan in hyponatremia, sponsored by Cumberland Pharmaceuticals. Started Apr 2007; status: completed.

02

Drugs

conivaptan
03

Conditions

hyponatremia

Beyond the preview

Go deeper on NCT00478192.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00478192.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call